The fate of Crispr and CRSP stock will be determined by the success of other drugs in the company's pipeline rather than Casgevy. More
Articles
SOFI Stock Rebound: Sell Into Strength or Let it Ride?
As sentiment for SOFI stock has quickly shifted back to bullish, let's see whether momentum can stay on its side in 2024. More
AMD Stock Hits 52-Week High: Time to Buy or Exercise Caution?
As before, feel free to maintain an existing AMD stock position, but for those looking to enter or add to a position, take your time. More